Skip to content
Physician
ENARFR
Sign InCart
Metabolic & Weight Management

Survodutide

GLP-1/glucagon dual receptor agonist studied for weight management and liver-fat research.

Weight-management researchLiver-fat marker studiesMetabolic research
Survodutide vial
How it works in the body
Human anatomy reference
Liver
Stomach
Pancreas
Adipose Tissue
RESEARCH USE ONLYINVESTIGATIONAL COMPOUND

Vial concentration

Survodutide

5 mg
Available following assessment

This is a clinician-reviewed research peptide. Pricing is provided as part of an approved, personalized plan after your assessment is reviewed.

REGENEXA ASSESSMENT

Not sure where to start?

Discover what may fit your goals — a short, personalized Regenexa Assessment.

Take Your Assessment →
  • 🔒 Secure & encrypted checkout
  • 📦 Fast, discreet worldwide shipping
  • 🧪 Pharmaceutical-grade quality
  • 🔬 Research use only
Not sure where to start? Discover what may fit your goals — a short, personalized Regenexa Assessment.Take Your Assessment →

Balanced dual agonism combines GLP-1-driven appetite suppression with glucagon-receptor-driven hepatic lipid oxidation, a mechanism of particular research interest for liver-fat (NASH) endpoints.

Receptors

GLP-1 receptorGlucagon receptor

Half-life: Supports once-weekly research dosing (published PK data indicates a multi-day half-life consistent with the class).

REGENEXA AI

Ask Regenexa AI about Survodutide

Get plain-language answers on mechanism, evidence and how it compares to other peptides — grounded in Regenexa's verified data.

“Does Survodutide help with liver fat specifically?”Ask Regenexa AI →
Available following assessmentTake Assessment

Related peptides in Metabolic & Weight Management

GLP-3 RGLP-3 RMetabolic & Weight ManagementAvailable following assessmentCagrilintideCagrilintideMetabolic & Weight ManagementAvailable following assessmentCagriSemaCagriSemaMetabolic & Weight ManagementAvailable following assessmentMazdutideMazdutideMetabolic & Weight ManagementAvailable following assessment